Cargando…
Randomised trial of proton vs. carbon ion radiation therapy in patients with low and intermediate grade chondrosarcoma of the skull base, clinical phase III study
BACKGROUND: Low and intermediate grade chondrosarcomas are relative rare bone tumours. About 5-12% of all chondrosarcomas are localized in base of skull region. Low grade chondrosarcoma has a low incidence of distant metastasis but is potentially lethal disease. Therefore, local therapy is of crucia...
Autores principales: | Nikoghosyan, Anna V, Rauch, Geraldine, Münter, Marc W, Jensen, Alexandra D, Combs, Stephanie E, Kieser, Meinhard, Debus, Jürgen |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2991309/ https://www.ncbi.nlm.nih.gov/pubmed/21050498 http://dx.doi.org/10.1186/1471-2407-10-606 |
Ejemplares similares
-
Randomised trial of proton vs. carbon ion radiation therapy in patients with chordoma of the skull base, clinical phase III study HIT-1-Study
por: Nikoghosyan, Anna V, et al.
Publicado: (2010) -
Proton Therapy for Skull Base Chondrosarcoma
por: Tang, Dennis M., et al.
Publicado: (2023) -
Glioblastoma radiotherapy using Intensity modulated Radiotherapy (IMRT) or proton Radiotherapy—GRIPS Trial (Glioblastoma Radiotherapy via IMRT or Proton BeamS): a study protocol for a multicenter, prospective, open-label, randomized, two-arm, phase III study
por: König, Laila, et al.
Publicado: (2021) -
Randomized phase II study evaluating a carbon ion boost applied after combined radiochemotherapy with temozolomide versus a proton boost after radiochemotherapy with temozolomide in patients with primary glioblastoma: The CLEOPATRA Trial
por: Combs, Stephanie E, et al.
Publicado: (2010) -
Combined treatment of adenoid cystic carcinoma with cetuximab and IMRT plus C12 heavy ion boost: ACCEPT [ACC, Erbitux(® )and particle therapy]
por: Jensen, Alexandra D, et al.
Publicado: (2011)